Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Homology Medicines stock

Learn how to easily invest in Homology Medicines stock.

Homology Medicines Inc is a biotechnology business based in the US. Homology Medicines shares (FIXX) are listed on the NASDAQ and all prices are listed in US Dollars. Homology Medicines employs 224 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Homology Medicines

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FIXX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Homology Medicines stock price (NASDAQ: FIXX)

Use our graph to track the performance of FIXX stocks over time.

Homology Medicines shares at a glance

Information last updated 2022-06-25.
Latest market close$1.97
52-week range$1.30 - $8.90
50-day moving average $1.77
200-day moving average $3.99
Wall St. target price$11.64
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.05

Buy Homology Medicines shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
$0
$0
N/A
Financial advice powered by relationships, not commissions.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Homology Medicines stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Homology Medicines price performance over time

Historical closes compared with the close of $1.97 from 2022-06-29

1 week (2022-06-23) -12.44%
1 month (2022-05-26) N/A
3 months (2022-03-26) N/A
6 months (2021-12-26) N/A
1 year (2021-06-30) -72.90%
2 years (2020-06-30) -87.03%
3 years (2019-06-28) 19.57
5 years (2017-06-26) N/A

Homology Medicines financials

Revenue TTM $5.5 million
Gross profit TTM $-59,114,000
Return on assets TTM -30.34%
Return on equity TTM -1.11%
Profit margin -47.29%
Book value $4.64
Market capitalisation $116.5 million

TTM: trailing 12 months

Homology Medicines share dividends

We're not expecting Homology Medicines to pay a dividend over the next 12 months.

Homology Medicines share price volatility

Over the last 12 months, Homology Medicines's shares have ranged in value from as little as $1.3 up to $8.9. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Homology Medicines's is -0.2141. This would suggest that Homology Medicines's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Homology Medicines has bucked the trend.

Homology Medicines overview

Homology Medicines, Inc. , a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc.

Frequently asked questions

What percentage of Homology Medicines is owned by insiders or institutions?
Currently 9.148% of Homology Medicines shares are held by insiders and 61.83% by institutions.
How many people work for Homology Medicines?
Latest data suggests 224 work at Homology Medicines.
When does the fiscal year end for Homology Medicines?
Homology Medicines's fiscal year ends in December.
Where is Homology Medicines based?
Homology Medicines's address is: One Patriots Park, Bedford, MA, United States, 01730
What is Homology Medicines's ISIN number?
Homology Medicines's international securities identification number is: US4380831077
What is Homology Medicines's CUSIP number?
Homology Medicines's Committee on Uniform Securities Identification Procedures number is: 438083107

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site